TY - JOUR
T1 - Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170
AU - Dunning, Alison M
AU - Michailidou, Kyriaki
AU - Kuchenbaecker, Karoline B
AU - Thompson, Deborah
AU - French, Juliet D
AU - Beesley, Jonathan
AU - Healey, Catherine S
AU - Kar, Siddhartha
AU - Pooley, Karen A
AU - Lopez-Knowles, Elena
AU - Dicks, Ed
AU - Barrowdale, Daniel
AU - Sinnott-Armstrong, Nicholas A
AU - Sallari, Richard C
AU - Hillman, Kristine M
AU - Kaufmann, Susanne
AU - Sivakumaran, Haran
AU - Moradi Marjaneh, Mahdi
AU - Lee, Jason S
AU - Hills, Margaret
AU - Jarosz, Monika
AU - Drury, Suzie
AU - Canisius, Sander
AU - Bolla, Manjeet K
AU - Dennis, Joe
AU - Wang, Qin
AU - Hopper, John L
AU - Southey, Melissa C
AU - Broeks, Annegien
AU - Schmidt, Marjanka K
AU - Lophatananon, Artitaya
AU - Muir, Kenneth
AU - Beckmann, Matthias W
AU - Fasching, Peter A
AU - Dos-Santos-Silva, Isabel
AU - Peto, Julian
AU - Sawyer, Elinor J
AU - Tomlinson, Ian
AU - Burwinkel, Barbara
AU - Marme, Frederik
AU - Guénel, Pascal
AU - Truong, Thérèse
AU - Bojesen, Stig E
AU - Flyger, Henrik Lavlund
AU - González-Neira, Anna
AU - Perez, Jose I A
AU - Anton-Culver, Hoda
AU - Eunjung, Lee
AU - Arndt, Volker
AU - Brenner, Hermann
AU - EMBRACE
PY - 2016/3/29
Y1 - 2016/3/29
N2 - We analyzed 3,872 common genetic variants across the ESR1 locus (encoding estrogen receptor α) in 118,816 subjects from three international consortia. We found evidence for at least five independent causal variants, each associated with different phenotype sets, including estrogen receptor (ER(+) or ER(-)) and human ERBB2 (HER2(+) or HER2(-)) tumor subtypes, mammographic density and tumor grade. The best candidate causal variants for ER(-) tumors lie in four separate enhancer elements, and their risk alleles reduce expression of ESR1, RMND1 and CCDC170, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.
AB - We analyzed 3,872 common genetic variants across the ESR1 locus (encoding estrogen receptor α) in 118,816 subjects from three international consortia. We found evidence for at least five independent causal variants, each associated with different phenotype sets, including estrogen receptor (ER(+) or ER(-)) and human ERBB2 (HER2(+) or HER2(-)) tumor subtypes, mammographic density and tumor grade. The best candidate causal variants for ER(-) tumors lie in four separate enhancer elements, and their risk alleles reduce expression of ESR1, RMND1 and CCDC170, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.
KW - Base Sequence
KW - Breast Neoplasms
KW - Carrier Proteins
KW - Cell Cycle Proteins
KW - Chromosomes, Human, Pair 6
KW - Estrogen Receptor alpha
KW - Female
KW - Gene Expression
KW - Gene Expression Regulation, Neoplastic
KW - Genetic Association Studies
KW - Genetic Predisposition to Disease
KW - Humans
KW - Phenotype
KW - Polymorphism, Single Nucleotide
KW - Protein Binding
KW - Risk Factors
KW - Journal Article
KW - Meta-Analysis
KW - Research Support, N.I.H., Extramural
KW - Research Support, Non-U.S. Gov't
KW - Research Support, U.S. Gov't, Non-P.H.S.
U2 - 10.1038/ng.3521
DO - 10.1038/ng.3521
M3 - Journal article
C2 - 26928228
SN - 1061-4036
VL - 48
SP - 374
EP - 386
JO - Nature Genetics
JF - Nature Genetics
IS - 4
ER -